台股 » 個股 » 錦明 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

錦明

(3230)
可現股當沖
  • 股價
    54.7
  • 漲跌
    ▼0.8
  • 漲幅
    -1.44%
  • 成交量
    790
  • 產業
    上櫃 光電類股▼0.07%
  • 46人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
錦明 (3230)籌碼相關-永豐金-台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-台中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1700.00157.8055.40-13,952-0.03%
2025/01/15253.40253.2053.0003,9790.00%
2025/01/13352.47452.1552.10-14,105-0.02%
2025/01/10153.8000.0053.8014,1280.02%
2025/01/092155.882154.5553.9004,3510.00%
2025/01/08357.60357.1357.2004,4680.00%
2025/01/071257.821257.5256.9004,5220.00%
2025/01/06158.80159.1059.1004,5570.00%
2025/01/03359.63460.6558.80-14,542-0.02%
2025/01/02159.5000.0059.7014,4900.02%
2024/12/31361.57261.7061.4014,4620.02%
2024/12/303562.343562.9561.4004,4020.00%
2024/12/27862.551162.7262.90-34,352-0.07%
2024/12/26565.98467.5865.9014,2090.02%
2024/12/25859.59959.9163.00-13,845-0.03%
2024/12/242261.633161.5559.50-93,739-0.24%
2024/12/23362.900.362.7063.002.73,4160.08%
2024/12/20057.201.157.6957.30-1.13,240-0.03%
2024/12/191.158.150.155.8058.0013,3140.03%
2024/12/16854.60753.2053.2013,7020.03%
2024/12/12256.50257.5056.7003,7810.00%
2024/12/11255.75256.0055.9003,8060.00%
2024/12/06057.8000.0056.6003,9220.00%
2024/12/0512.158.72358.2759.609.14,0140.23%
2024/12/03458.78457.8857.4004,0680.00%
2024/12/021258.77758.5058.4054,0190.12%
2024/11/29157.0000.0056.4013,9360.03%
2024/11/28953.23953.6753.8003,8520.00%
2024/11/27161.4000.0054.6013,8140.03%
2024/11/263.359.91560.2460.60-1.73,641-0.05%
2024/11/25257.40256.3055.1003,5500.00%
2024/11/22256.10755.8355.80-53,535-0.14%
2024/11/21955.134.455.6256.004.63,5130.13%
2024/11/2000.00152.3052.30-13,490-0.03%
2024/11/19352.43351.2052.4003,4770.00%
2024/11/15249.90250.0051.0003,4990.00%
2024/11/14551.645.151.4351.20-0.13,5190.00%
2024/11/136.553.63753.8152.50-0.53,568-0.01%
2024/11/121356.101054.8653.6033,6390.08%
2024/11/111857.8718.158.6057.70-0.13,6360.00%
2024/11/08256.25456.6854.80-23,630-0.06%
2024/11/07956.998.158.3857.700.93,6240.03%
2024/11/0618.156.092256.4457.80-3.93,565-0.11%
2024/11/0528.156.412456.1655.404.13,4820.12%
2024/11/041355.041155.1754.9023,4080.06%
2024/11/01151.10449.1951.40-33,258-0.09%
2024/10/30245.03245.6346.8003,2500.00%
2024/10/29446.95247.8545.4523,2800.06%
2024/10/28449.26650.3848.50-23,288-0.06%
2024/10/25350.80148.3048.9023,2650.06%
2024/10/2400.00051.5051.4003,2730.00%
2024/10/231152.921152.2952.2003,2900.00%
2024/10/221352.941652.3852.60-33,305-0.09%
2024/10/21352.23354.9051.6003,2820.00%
2024/10/18257.601261.0857.00-103,257-0.31%
2024/10/17161.6000.0061.7013,2800.03%
2024/10/167863.497964.1162.90-13,306-0.03%
2024/10/15361.203.163.1063.10-0.13,0980.00%
2024/09/3000.00257.0057.00-22,968-0.07%
2024/09/2400.000.150.0054.00-0.12,9680.00%
2024/09/23853.39853.0052.0002,9610.00%
2024/09/20356.106.157.0054.30-3.12,846-0.11%
2024/09/190.149.73149.7554.60-0.92,629-0.03%
2024/09/18249.33049.8049.6522,4620.08%
2024/09/1300.00141.8041.50-12,287-0.04%
2024/09/12039.9000.0039.1002,2410.00%
2024/09/10537.5500.0037.5552,1600.23%
2024/09/09139.2000.0038.8012,0690.05%
2024/09/06242.0500.0042.6021,9890.10%
2024/09/052.145.60145.6044.051.11,8500.06%
2024/09/0400.0014048.9248.90-1401,778-7.87% 大賣/鉅額交易
2024/09/0300.00254.6054.30-21,699-0.12%
2024/08/2700.00445.0046.20-41,788-0.22%
2024/08/21138.3000.0043.7511,8110.06%
2024/08/20537.9500.0040.2051,8030.28%
2024/08/1900.00136.5536.55-11,781-0.06%
2024/08/1600.00132.7033.25-11,772-0.06%
2024/08/1500.00232.2332.70-21,766-0.11%
2024/08/1400.001030.2529.75-101,720-0.58%
2024/08/1300.00127.9527.95-11,654-0.06%
2024/08/1200.00125.3025.45-11,652-0.06%
2024/08/09123.1000.0023.1511,6290.06%
2024/08/08121.355622.4023.05-551,695-3.24%
2024/08/0700.00520.8021.70-51,692-0.30%
2024/08/052620.6300.0020.60261,7101.52%
2024/08/02223.701024.1022.85-81,685-0.47%
2024/08/011023.0010.123.0024.75-0.11,6510.00%
2024/07/310.122.50023.0022.500.11,6070.00%
2024/07/30221.5500.0021.5521,5870.13%
2024/07/29321.7600.0021.7531,5940.19%
2024/07/23920.4000.0020.8091,5240.59%
2024/07/22321.6300.0021.6031,4990.20%
2024/07/19123.8500.0023.9511,4760.07%
2024/07/181120.75221.8021.8091,4450.62%
2024/07/173518.59219.8019.85331,3592.43%
2024/07/161517.8700.0018.05151,2771.17%
2024/07/0900.00618.2517.40-61,202-0.50%
2024/07/0800.00118.9018.90-11,143-0.09%
2024/06/251015.301514.7015.40-51,021-0.49%
2024/06/243815.9600.0015.25381,0133.75%
2024/06/19516.50516.7516.4501,0000.00%
2024/06/181516.49116.4016.45149921.41%
2024/06/131816.211016.2016.2089580.83%
2024/06/1200.00215.7016.20-2956-0.21%
2024/06/11716.3600.0016.0079580.73%
2024/06/061716.8300.0016.60179411.81%
2024/06/05317.05517.1017.05-2923-0.22%
2024/06/04516.881316.5817.40-8903-0.89%
2024/05/311315.3500.0015.15138381.55%
2024/05/3000.001315.5515.40-13849-1.53%
2024/05/281014.401014.7014.7008020.00%
2024/05/271014.45514.4014.4057980.63%
2024/05/23214.30114.3014.2518060.12%
2024/05/221214.5400.0014.80128011.50%
2024/05/21515.1200.0014.5557940.63%
2024/05/20216.0000.0016.1027800.26%
2024/05/17316.6200.0016.5038090.37%
2024/05/16116.15316.7516.80-2788-0.25%
2024/05/15115.5000.0015.9017580.13%
2024/05/143115.5500.0015.55317114.36%
2024/05/10213.8300.0013.6026370.31%
2024/05/09513.7900.0013.8056260.80%
2024/05/02313.3200.0013.2536360.47%
2024/04/30212.4000.0012.2526140.33%
2024/04/2600.00812.5012.40-8596-1.34%
2024/04/25412.08312.5512.4015740.17%
2024/04/24212.0000.0012.0025420.37%
2024/04/2200.00110.009.98-1494-0.20%
2024/04/10110.1500.0010.2015060.20%
2024/04/08010.3000.0010.3505040.00%
2024/04/03011.6000.0010.4005040.00%
2024/03/11210.9300.0010.9524610.43%
2024/03/08211.0500.0011.1524590.44%
2024/03/06211.8000.0011.8024510.44%
2024/03/05412.3500.0012.3044400.91%
2024/03/0400.00211.9011.90-2419-0.48%
2024/03/01210.901011.1010.85-8408-1.96%
2024/02/2900.00111.2511.20-1410-0.24%
2024/02/27110.7000.0011.3514100.24%
2024/02/23512.3000.0012.1054061.23%
2024/02/2200.00312.2212.50-3417-0.72%
2024/02/21612.80112.8012.5554161.20%
2024/02/20213.2013313.3913.40-131388-33.74% 大賣/鉅額交易
2024/02/1900.00212.0012.20-2339-0.59%
2024/02/16211.2000.0011.1023280.61%
寶齡富錦明日停牌 傳將公布腎臟新藥中國三期臨床結果Anue鉅亨-2022/02/21
錦明 相關文章
錦明 相關影音